Federal Register / Vol. 70, No.
235 / Thursday, December 8, 2005 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Research
Program Projects.
Date: December 6, 2005.
Time: 9 a.m to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Helen Lin, Ph.D.,
Scientific Review Administrator, NIH/
NIAMS/RB, 6701 Democracy Blvd., Suite
800, Plaza One, Bethesda, MD 20817. 301–
594–4952. linh1@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: November 29, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–23793 Filed 12–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
VerDate Aug<31>2005 16:29 Dec 07, 2005 Jkt 208001
73017
Emphasis Panel Mentored Patient-Oriented
Research Career Development Award (K23).
Date: December 15, 2005.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIEHS/National Institutes of Health,
Building 4401, East Campus, 79 T.W.
Alexander Drive, Research Triangle Park, NC
27709. (Telephone Conference Call).
Contact Person: Linda K. Bass, PhD,
Scientific Review Administrator, Nat’l
Institutes of Environmental Health Sciences,
P.O. Box 12233, MD EC–24, Research
Triangle Park, NC 27709. (919) 541–1307.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: November 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–23794 Filed 12–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Allergy and
Infectious Diseases, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIAID. Division of Intramural
Research, Board of Scientific Counselors.
PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\08DEN1.SGM
Date: December 5–7, 2005.
Time: December 6, 2005, 8 a.m. to 5 p.m.
Agenda: To review and evaluate review of
intramural laboratories.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Room 1227/1233, Bethesda, MD 20892.
Time: December 6, 2005, 8 a.m. to 5 p.m.
Agenda: To review and evaluate review of
intramural laboratories.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Room 1227/1233, Bethesda, MD 20892.
Time: December 7, 2005, 8 a.m. to 10:30
a.m.
Agenda: To review and evaluate review of
intramural laboratories.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Room 1227/1233, Bethesda, MD 20892.
Contact Person: Kathryn C. Zoon, PhD,
Acting Director, Division of Intramural
Research, National Institute of Allergy and
Infectious Diseases, NIH, Building 31, Room
4A30, Bethesda, MD 20892, 301–496–3006,
kzoon@niaid.nih.gov.
This meeting is being published less than
15 days prior to the meeting date because of
an administrative error.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: November 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–23796 Filed 12–7–05:8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel.
Hurricane Katrina Time Sensitive Review.
Date: December 16, 2005.
08DEN1
 73018 Federal Register / Vol. 70, No. 235 / Thursday, December 8, 2005 / Notices
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Meenaxi Hiremath, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6101 Executive Blvd., Suite 220, MSC
8401, Bethesda, MD 20892, 301–402–7964,
mh392g@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: November 30, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–23800 Filed 12–7–05; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meeting
Notice is hereby given of the first
meeting of the Working Group on
Chemical Information Resource
Coordination under the National Library
of Medicine’s (NLM) Board of Scientific
Counselors, National Center for
Biotechnology Information (NCBI).
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The mission of the Working Group on
Chemical Information Resource
Coordination is to advise the Board of
Scientific Counselors, NCBI, on
interactions with private sector
information providers in the
development of the PubChem database.
PubChem is a publicly available
database that includes information
about the biological activities of
chemical compounds, and is designed
to facilitate more integrated access to
these information resources for
biomedical researchers. The working
group will: (1) Establish a process for
retrospective evaluation of the
biomedical relevance of compounds
entered into PubChem, (2) Ensure the
provenance of the data (i.e., whether
VerDate Aug<31>2005 16:29 Dec 07, 2005 Jkt 208001
private data are being improperly
deposited into PubChem), (3) Ensuring
the high quality of data in PubChem, (4)
Monitoring the effect of PubChem on
scientific progress, (5) Improving/
integrating interactions with
commercial information providers, and
(6) Avoiding unnecessary duplication
with commercial information providers.
This working group supports part of the
National Institutes of Health’s Roadmap,
called the Molecular Libraries Initiative.
Name of Committee: Working Group on
Chemical Information Resource
Coordination.
Date: December 19, 2005.
Time: 9 a.m. to 4 p.m.
Agenda: Discussion on the NLM/NCBI
PubChem Database.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20894.
Contact Person: David J. Lipman, MD,
Director, National Center for Biotechnology
Information, National Library of Medicine,
NIH, Building 38A, Room 8N803, Bethesda,
MD 20894, 301–496–2475.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The comment should include the
name, address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
Dated: November 29, 2005.
Nancy Middendorf,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–23792 Filed 12–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the Board
of Regents of the National Library of
Medicine.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\08DEN1.SGM
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Regents of
the National Library of Medicine Extramural
Programs Subcommittee.
Date: February 6, 2006.
Closed: 4 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, Conference Room B, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496–6221, lindberg@mail.nih.gov.
Name of Committee: Board of Regents of
the National Library of Medicine
Subcommittee on Outreach and Public
Information.
Date: February 7, 2006.
Open: 7:30 a.m. to 8:45 a.m.
Agenda: Outreach Activities.
Place: National Library of Medicine,
Building 38, Conference Room B, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496–6221, lindberg@mail.nih.gov.
Name of Committee: Board of Regents of
the National Library of Medicine.
Date: February 7–8, 2006.
Open: February 7, 2006, 9 a.m. to 4:30 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Closed: February 7, 2006, 4:30 p.m. to 5
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Open: February 8, 2006, 9 a.m. to 12 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496–6221, lindberg@mail.nih.gov.
Name of Committee: Board of Regents of
the National Library of Medicine Planning
Subcommittee.
Date: February 8, 2006.
Open: 7:30 a.m. to 8:45 a.m.
Agenda: Long-Range Planning.
Place: National Library of Medicine,
Building 38, Conference Room B, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496–6221, lindberg@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
08DEN1